MME and Alzheimer disease: The culture medium from EGCG-treated astrocytes facilitated the degradation of exogenous Aβ, suggesting that EGCG may have a beneficial effect on persons with AD by activating ERK- and PI3K-mediated pathways in astrocytes, thereby increasing astrocyte secretion of NEP and facilitating degradationofAβ [80].